Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

Hematology is the branch of medicine which deals with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. It involves treating diseases which affects the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. Hematology mainly focused on blood components like blood cells, hemoglobin, blood proteins, bone marrow, spleen and Coagulation mechanism. Physicians who work on treating hematologic disorders, referred to as Hematologists.

Blood is a fluid in the body of humans and other animals that delivers necessary substances such as nutrients and oxygen to the cells and transports metabolic waste products away from same cells. In which blood is circulated around the body through blood vessels by the pumping action of the heart.

  • Track 1-1 Hematologic neoplasms
  • Track 1-2 Lymphoma
  • Track 1-3 Hematologic neoplasms
  • Track 1-4 Blood coagulation Mechanism
  • Track 1-5 Hematopathology
  • Track 1-6 Hemophilia
  • Track 1-7 Prenatal Diagnosis

Blood is a body fluid that moves through the vessels of a circulatory system. In humans, it contains plasma, blood cells (red and white blood cells), and cell fragments called platelets. Cells and platelets make up about 45%percent percent of human blood, while plasma makes up the other 55%percent percent.

  • Track 2-1 Red Blood Cells
  • Track 2-2 White Blood Cells
  • Track 2-3 Platelets
  • Track 2-4 Plasma
  • Track 2-5 Blood Cell Production

Peoples may be affected by many different types of blood conditions and blood cancers. Common blood disorders include anemia, bleeding disorders such as blood clots and hemophilia and blood cancers such as leukemia, lymphoma, and myeloma. It mainly affects red and white blood cells, plasma, and platelets. A larger part of the blood issue is caused by transformations qualities and can be passed to the families. Blood disorders are conditions that affect the blood capacity to work accurately.

  • Track 3-1 Anemia & Leukemia
  • Track 3-2 Thalassemia
  • Track 3-3 Myelodysplastic Syndrome
  • Track 3-4 Hemophilia

After the physical examination, for the detection of blood disorders physician usually go for complete blood count. This is the basic test after that to diagnose a persons blood disorder, the doctor usually must do further blood tests once a consultant finds that something is wrong with one or more of the blood cell types, many additional tests are available for further detection of disease. Doctors can measure proportion of the different types of WBCs and can also determine subtypes of these cells by assessing certain markers on the surface of the cells. Tests are made to measure the ability of white blood cells to fight foreign body infection, to evaluate the functioning of blood platelets and their ability to clot and to check the contents of red blood cells to help determine the cause of anemia or why the cells are not functioning properly. Most of these tests are done on blood samples, but sometime require a bone marrow samples as well for Bone Marrow Examination. Once the problem is diagnosed Hematologists go for the appropriate treatment for the problem.

 

  • Track 4-1 Complete Blood Count (CBC)
  • Track 4-2 Screening Tests
  • Track 4-3 Bone Marrow Examination and Biopsy
  • Track 4-4 Bone Marrow Transplantation
  • Track 4-5 Gene Therapy
  • Track 4-6 Cord Blood Transplantation

Transfusion of blood is the process of receiving whole blood or blood products into one’s systemic circulation intravenously. It may include injection of whole blood or components such as red blood cells, white blood cells, plasma, platelets or clotting factors. Blood transfusion is usually done in cases of deficiencies, to increase the oxygen saturation, during accidents or during surgery, to treat hematologic conditions such as severe anemia, leukemia, and sickle cell disease. Blood transfusion may also be associated with various complications including infections, immunological disorders such as hemolysis or incompatibilities.

  • Track 5-1 Red and White Blood Cell Transfusion
  • Track 5-2 Platelet Transfusion
  • Track 5-3 Autologous Blood
  • Track 5-4 Reactions of Transfusion
  • Track 5-5 Testing of Compatibility

Blood or bone marrow transplant replaces abnormal blood-forming stem cells with healthy cells. When the healthy stem cells come from you, the procedure is called an autologous transplant. When the stem cells come from another person, called a donor, it is an allogeneic transplant.

Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. Hemostasis is a process to prevent and stop bleeding, meaning to keep blood within a damaged blood vessel. It is the first stage of wound healing.

  • Track 6-1 Thromboembolism
  • Track 6-2 Venous and Arterial Thrombosis
  • Track 6-3 Vasoconstriction
  • Track 6-4 Blood coagulation
  • Track 6-5 Von Willebrand Factor

Hematologic disorders can affect the central and peripheral nervous systems in several different ways, producing a wide range of neurologic disturbances. They result in nervous system disfunction through a variety of mechanisms, including vascular occlusion, hemorrhage, infiltration and metabolic disturbance, which may be hereditary or acquired. Its frequent cause of certain syndromes, such as venous thrombosis, but rarer causes of a wide range of neurologic conditions. Hematologic disease should be considered as a cause of subacute multifocal disorders.

  • Track 7-1 Thrombophilia
  • Track 7-2 Thrombocytopenic purpura
  • Track 7-3 Clonal Disorders
  • Track 7-4 Sickle cell anemia
  • Track 7-5 Hypercoagulability and thrombophilia

Hematologic oncology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood. Haematology includes the study of etiology. It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. The laboratory work that goes into the study of blood is frequently performed by a medical technologist or medical laboratory scientist. Hematologists also conduct studies in oncology and work with oncologists, people who may specialize only in that field instead of both-the medical treatment of cancer. There are various disorders that people are affected by Haematology. A few of these different types of blood conditions that are looked at include Anemia, Hemophilia, general blood clots, bleeding disorders, etc. As for related blood cancers such as Leukemia, myeloma, and lymphoma, these are more serious cases that need to be diagnosed- Myeloma, Myelodysplastic syndromes, Multiple Myeloma, Leukemia, Lymphoma.

  • Track 8-1 Acute and Chronic Lymphoblastic Leukemia
  • Track 8-2 Multiple Myeloma
  • Track 8-3 Hodgkin and Non-Hodgkin Lymphoma
  • Track 8-4 Myeloid Leukemia
  • Track 8-5 Myelodysplastic Syndromes

Hematological malignancies are forms of the cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Examples of hematologic cancer are acute and chronic leukemias, lymphomas, multiple myeloma and myelodysplastic syndromes. Genetic characterization is vital role in the clinical evaluation of nearly every form of hematologic malignancy. Here, we review how genetic analysis contributes to the diagnosis and/or management of acute leukemias, chronic myeloid neoplasms, B- and T-/natural killer (NK)-cell lymphomas, as well as multiple myeloma.

 

  • Track 9-1 Non-Hodgkin Lymphoma
  • Track 9-2 Acute myeloid leukemia
  • Track 9-3 Acute lymphoblastic leukemia
  • Track 9-4 Myeloproliferative Disorders
  • Track 9-5 Generic drugs

The overall market for the hematological pharmaceuticals in top point as it is as often as possible foreseen to be improved over two or three decades. According to the overall market master, the hematology cure and definite market is depended upon to create at the rate of 7.5% from 2015-2020. A portion of the best drug store enterprises creating biological drugs and Generic Drugs fuse. Takeda Oncology, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, AstraZeneca, Merck and Co., Amgen, Janssen bio tech, Pfizer, Bayer, Otsuka, Sanofi, Astellas, Eisai, AbbVie, Pharmacyclics.

 

  • Track 10-1 Biological drugs
  • Track 10-2 Increased investments
  • Track 10-3 Healthcare expenditures

Stem cell research deals with research and publication of high-quality manuscripts related to stem cells. Stem cells are cells of multicellular organisms that can differentiate into other types of cells. They can divide more cells of the same type of stem cells. For a cell to be considered a stem cell, it should be self-renewing and must be either totipotent or pluripotent. Various types of stem cells such as embryonic stem cells, fetal and adult stem cells tissue specific stem cells, haemopoietic stem cells, cancer stem cells are known. Haemopoietic stem cells that give rise to other blood cells by a process called Hemopoiesis in the red bone marrow. Haemopoietic stem cell transplants are used in the treatment of cancers and other immune system disorders.

  • Track 11-1 Stem cell transplantation
  • Track 11-2 Tissue regeneration
  • Track 11-3 Stem cell products
  • Track 11-4 Stem cell therapy
  • Track 11-5 Stem cell biomarkers

Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature and therefore do not become healthy blood cells. Early on, there are typically no symptoms. Later symptoms may include feeling tired, shortness of breath, easy bleeding, or frequent infections. Some types may develop into acute myeloid leukemia. It causes when exposure to certain chemicals such as tobacco smoke, pesticides, and benzene, and exposure to heavy metals such as mercury or lead.

 

  • Track 12-1 Thrombocytopenia
  • Track 12-2 Stem cell transplantation
  • Track 12-3 Acute Myelogenous Leukemia

It is the branch of medicine that deals with the study of blood, blood disease and the organs involved in forming blood. The diagnosis and treatment of hematological disorders is mainly managed by specialists in the field referred to as hematologists.

Biomarkers in hematology were mostly of protein biomarkers which are useful to detect the tumors early location and mainly to identify bosom growth, these biomarkers simply used to measure and indicate the severity level of disease state. Whereas these hematological biomarkers are helpful in identifying the blood disease. Patients who are suspected with pancreatic malignancy will face CT sweep. Recolors neoplastic pancreatic cells will empower the certainty to identify pancreatic tumor by pathologist and hence suitable for treating disease condition. For pancreatic disease a novel drug discovery in biomarkers like BI-010 and IHC markers are developed.

  • Track 14-1 Drug Targeting
  • Track 14-2 Prognosis and treatment production
  • Track 14-3 Pharmacodynamics and Pharmacokinetics
  • Track 14-4 Monitoring treatment response
  • Track 14-5 Acute kidney failure

Immunohematology are commonly known as blood banking is a branch of hematology which studies antigen-antibody reactions and analogous phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders. This is the laboratory medicine dealing with preparing blood components, blood for appropriate selection and transfusion and components that are compatible for transfusion which is helpful for the case of severe blood loss or low blood levels. Red blood cells contain antigens and protein markers on their surfaces, if recipient or donors red blood cells doesn’t contain this antigen the antigen lacking individual will lead to form antibodies which destroys the red blood cells

 

  • Track 15-1 Auto Immune Hemolytic Anemia (AIHA)
  • Track 15-2 Transfusion related acute lung injury (TRALI)
  • Track 15-3 Antibody screening
  • Track 15-4 Clinical immunology

Pediatric Haematology is an international peer-reviewed medical journal that covers all aspects of pediatric hematology. The journal covers immunology, pathology, and pharmacology in relation to blood diseases in children and shows how basic experimental research can contribute to the understanding of clinical problems. Physicians specialized in hematology are known as hematologists or hematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the hematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various hematological test results and blood clotting test results. In some institutions, hematologists also manage the hematology laboratory. Physicians who work in hematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of hematological diseases, referred to as hematopathologists or hematopathologists.

 

  • Track 16-1 Clinical Hematology and Hematopathology
  • Track 16-2 Experimental Hematology and Ethical Issues
  • Track 16-3 Scope of Animal Haematology and Its Importance
  • Track 16-4 Hematology practice and Case Reports
  • Track 16-5 Contribution of Blood Banks and Blood Donation Programs
  • Track 16-6 Prospects of Hematology Research

A blood product may be defined as a therapeutic substance that is acquired from human blood. Some of the blood products are: Whole blood - which is rarely used in transfusion medicine. Blood components - Suspension of red blood cells, white blood cells and platelets; Plasma derivatives - Plasma proteins such as albumin, coagulation factor suspension and immunoglobulins.

 

Blood group antigens are polymeric residues of protein or carbohydrates on the red cell surface. They can provoke an antibody response in individuals who lack them, and some antibodies can lead to hemolytic transfusion reaction or hemolytic disease of the newborn. Researchers have identified the molecular basis of many red cell blood group antigens, and an actively maintained database currently lists over 1,600 alleles of 44 genes. This mini review describes the major applications of the explosion knowledge in blood group genetics to the practice of blood banking and transfusion medicine.

 

  • Track 18-1 Fetal Typing
  • Track 18-2 Transfused patients
  • Track 18-3 Immunoglobulin coated red cells
  • Track 18-4 RHD Zygosity
  • Track 18-5 Tests and Treatment for Anemia

During pregnancy anemia may developed. When women  having anemia during pregnancy time, your blood doesn't have enough healthy red blood cells to carry oxygen to your tissues and to your baby. During pregnancy, body produces more blood to support the growth of your baby. If you're not getting enough iron or certain other nutrients, your body might not be able to produce the amount of red blood cells it needs to make this additional blood. It’s normal to have mild anemia when you are pregnant. But you may have more severe anemia from low iron or vitamin levels or from other reasons. Anemia can leave you feeling tired and weak. If it is severe but goes untreated, it can increase your risk of serious complications like preterm delivery. Here’s what you need to know about the causes, symptoms, and treatment of anemia during pregnancy.

 

  • Track 19-1 Types of Anemia During Pregnancy
  • Track 19-2 Risk Factors During Pregnancy
  • Track 19-3 Symptoms

Hematology automation has progressed steadily since Wallace Coulter first applied electrical impedance technology to counting red cells and white cells. By the 1980s, most hematology laboratories were reporting out a 7-parameter complete blood count (CBC) and three-part differential obtained from a single aspiration on a stand-alone, bench-top instrument. Eventually, this process was upgraded even further when it became possible to obtain these results without uncapping the sample. When this became state-of-the-art, CBC turnaround time (TAT) was primarily dependent on how fast a laboratorian could do a manual 100-cell differential and/or a manual reticulocyte count.

 

  • Track 20-1 Clinical Decision Making
  • Track 20-2 Standardization
  • Track 20-3 Cross Training